Subscribe

0

PharmEasy

PharmEasyNews

PharmEasy eyes Rs 3,500 Cr investment via right issue

In August 2022, PharmEasy postponed its plans to launch an IPO amidst challenging market conditions.

By Kunal Manchanada
Aug 23, 2023 08:36 IST 2 Min read
term loanIn-Depth
Read the documents carefully: Should founders steer away from term loans?
By Jai Vardhan & Kul Bhushan
Jul 21, 2023 05:30 IST 4 Min read
PharmEasyNews
Janus Henderson cuts PharmEasy’s valuation by 50%
By Md Salman Ashrafi
May 15, 2023 08:07 IST 2 Min read
PharmEasyFintrackr
PharmEasy’s scale crosses Rs 5,700 Cr in FY22, losses mount 4X
By Harsh Upadhyay & Md Salman Ashrafi
Dec 22, 2022 10:39 IST 4 Min read
PharmEasyNews
PharmEasy’s parent API Holdings postpones IPO citing market conditions
By Kul Bhushan
Aug 20, 2022 11:33 IST 3 Min read
PharmEasyFintrackr
Diagnosing the PharmEasy DRHP
By Jai Vardhan and Gaurav Tyagi
Nov 12, 2021 09:52 IST 4 Min read
PharmEasyFintrackr
Unpacking PharmEasy’s pre-IPO round and current shareholding
By Harsh Upadhyay & Gaurav Tyagi
Oct 18, 2021 10:49 IST 2 Min read
Aknamed acquired by PharmEasy at $144 Mn valuation; co-founders exitFintrackr
Aknamed acquired by PharmEasy at $144 Mn valuation; co-founders exit
By Harsh Upadhyay & Gaurav Tyagi
Sep 14, 2021 11:45 IST 2 Min read
PharmEasy to buy a 66.1% stake in Thyrocare for Rs 4,546 CrNews
PharmEasy to buy a 66.1% stake in Thyrocare for Rs 4,546 Cr
By Harsh Upadhyay
Jun 25, 2021 16:26 IST 2 Min read
PharmEasyNews
PharmEasy raises $350 Mn round led by Prosus and TPG; enters unicorn club
By Harsh Upadhyay
Apr 07, 2021 05:47 IST 2 Min read
Prev 1 2 3 ... Next